Dendritic cells combined with anti-GITR antibody produce antitumor effects in osteosarcoma
Authors:
- 29 July 2015
- journal article
- Published by Spandidos Publications in Oncology Reports
- Vol. 34 (4) , 1995-2001
Abstract
Spandidos Publications is a scientific publisher with a long-standing international reputation for excellent standards and high quality science publicationsKeywords
This publication has 30 references indexed in Scilit:
- Inflammatory and regulatory T cells contribute to a unique immune microenvironment in tumor tissue of colorectal cancer patientsInternational Journal of Cancer, 2012
- Anti-TGF-β Antibody Combined with Dendritic Cells Produce Antitumor Effects in OsteosarcomaClinical Orthopaedics and Related Research, 2012
- Osteosarcoma in very young childrenCancer, 2010
- Cryoimmunologic Antitumor Effects Enhanced by Dendritic Cells in OsteosarcomaClinical Orthopaedics and Related Research, 2010
- Enhancement of T‐cell‐mediated anti‐tumour immunity via the ectopically expressed glucocorticoid‐induced tumour necrosis factor receptor‐related receptor ligand (GITRL) on tumoursImmunology, 2009
- Factors influencing the generation of murine dendritic cells from bone marrow: The special role of fetal calf serumImmunobiology, 2008
- Agonist Anti-GITR Antibody Enhances Vaccine-Induced CD8+ T-Cell Responses and Tumor ImmunityCancer Research, 2006
- In Vivo Kinetics of GITR and GITR Ligand Expression and Their Functional Significance in Regulating Viral ImmunopathologyJournal of Virology, 2005
- Triggering of OX40 (CD134) on CD4+CD25+ T cells blocks their inhibitory activity: a novel regulatory role for OX40 and its comparison with GITRBlood, 2005
- Frontline: GITR, a member of the TNF receptor superfamily, is costimulatory to mouse T lymphocyte subpopulationsEuropean Journal of Immunology, 2004